Lyon TD - Search Results

1

Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. Lyon TD, et al. Urology. 2020 Feb;136:111. doi: 10.1016/j.urology.2019.09.049. Urology. 2020. PMID: 32033664 No abstract available.

2

Should Urologists Abandon the Use of Mannitol During Partial Nephrectomy?

Shah PH, Leibovich BC, Lyon TD. Shah PH, et al. Among authors: lyon td. Eur Urol. 2018 Jan;73(1):60-61. doi: 10.1016/j.eururo.2017.09.017. Epub 2017 Oct 4. Eur Urol. 2018. PMID: 28985968 No abstract available.

3

Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.

Shah PH, Thompson RH, Boorjian SA, Lohse CM, Lyon TD, Shields RC, Froehling D, Leibovich BC, Viers BR. Shah PH, et al. Among authors: lyon td. J Urol. 2018 Sep;200(3):520-527. doi: 10.1016/j.juro.2018.04.069. Epub 2018 Apr 27. J Urol. 2018. PMID: 29709665

4

The Association of Aspirin Use with Survival Following Radical Cystectomy.

Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. Lyon TD, et al. J Urol. 2018 Nov;200(5):1014-1021. doi: 10.1016/j.juro.2018.05.119. Epub 2018 May 30. J Urol. 2018. PMID: 29857079

5

Temporal trends in venous thromboembolism after radical cystectomy.

Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA. Lyon TD, et al. Urol Oncol. 2018 Aug;36(8):361.e15-361.e21. doi: 10.1016/j.urolonc.2018.05.015. Epub 2018 Jun 7. Urol Oncol. 2018. PMID: 29885792

6

Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.

Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH. Shah PH, et al. Among authors: lyon td. BJU Int. 2019 Feb;123(2):270-276. doi: 10.1111/bju.14523. Epub 2018 Sep 9. BJU Int. 2019. PMID: 30113768

7

Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era.

Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Lyon TD, et al. Urol Oncol. 2018 Nov;36(11):499.e1-499.e7. doi: 10.1016/j.urolonc.2018.08.008. Epub 2018 Sep 15. Urol Oncol. 2018. PMID: 30228096

8

A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease.

Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA. Lyon TD, et al. World J Urol. 2019 Aug;37(8):1605-1613. doi: 10.1007/s00345-018-2551-9. Epub 2018 Nov 3. World J Urol. 2019. PMID: 30392012

9

Comprehensive characterization of perioperative reoperation following radical cystectomy.

Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK. Lyon TD, et al. Urol Oncol. 2019 Apr;37(4):292.e11-292.e17. doi: 10.1016/j.urolonc.2018.11.023. Epub 2019 Jan 22. Urol Oncol. 2019. PMID: 30679081

10

Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection.

Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA. Shah PH, et al. Among authors: lyon td. J Urol. 2019 Jul;202(1):69-75. doi: 10.1097/JU.0000000000000171. Epub 2019 Jun 7. J Urol. 2019. PMID: 30925222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters